Jim Simons’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.81M | Buy |
3,972,160
+932,382
| +31% | +$1.97M | 0.02% | 981 |
|
|
2025
Q4 | $6.23M | Buy |
3,039,778
+1,762,378
| +138% | +$5.09M | 0.01% | 1181 |
|
|
2025
Q3 | $4.43M | Buy |
1,277,400
+389,000
| +44% | +$1.09M | 0.01% | 1574 |
|
|
2025
Q2 | $1.95M | Sell |
888,400
-144,565
| -14% | -$237K | ﹤0.01% | 2128 |
|
|
2025
Q1 | $1.2M | Sell |
1,032,965
-418,084
| -29% | -$615K | ﹤0.01% | 2296 |
|
|
2024
Q4 | $1.84M | Buy |
+1,451,049
| New | +$3.7M | ﹤0.01% | 2108 |
|
|
2024
Q3 | – | Sell |
-98,429
| Closed | -$460K | – | 3614 |
|
|
2024
Q2 | $460K | Sell |
98,429
-799,989
| -89% | -$4.51M | ﹤0.01% | 2731 |
|
|
2024
Q1 | $6.67M | Buy |
898,418
+391,018
| +77% | +$3.25M | 0.01% | 1232 |
|
|
2023
Q4 | $5.14M | Buy |
507,400
+442,900
| +687% | +$3.89M | 0.01% | 1327 |
|
|
2023
Q3 | $503K | Sell |
64,500
-91,800
| -59% | -$787K | ﹤0.01% | 2701 |
|
|
2023
Q2 | $1.29M | Buy |
+156,300
| New | +$1.36M | ﹤0.01% | 2309 |
|
|
2022
Q2 | – | Sell |
-903,400
| Closed | -$17.2M | – | 4302 |
|
|
2022
Q1 | $17.2M | Buy |
903,400
+675,300
| +296% | +$12.6M | 0.02% | 839 |
|
|
2021
Q4 | $6.06M | Buy |
+228,100
| New | +$7.85M | 0.01% | 1398 |
|
|
2021
Q3 | – | Sell |
-140,000
| Closed | -$7.93M | – | 3551 |
|
|
2021
Q2 | $7.93M | Sell |
140,000
-315,927
| -69% | -$11.7M | 0.01% | 1335 |
|
|
2021
Q1 | $19.1M | Buy |
+455,927
| New | +$26M | 0.02% | 797 |
|
|
2020
Q4 | – | Sell |
-106,100
| Closed | -$2.98M | – | 3451 |
|
|
2020
Q3 | $2.98M | Sell |
106,100
-94,000
| -47% | -$3.06M | ﹤0.01% | 1880 |
|
|
2020
Q2 | $5.92M | Sell |
200,100
-100,800
| -33% | -$2.63M | 0.01% | 1533 |
|
|
2020
Q1 | $5.97M | Buy |
300,900
+218,800
| +267% | +$5.52M | 0.01% | 1464 |
|
|
2019
Q4 | $2.43M | Buy |
+82,100
| New | +$2.05M | ﹤0.01% | 2227 |
|
|
2019
Q2 | – | Sell |
-371,400
| Closed | -$9.08M | – | 3589 |
|
|
2019
Q1 | $9.08M | Buy |
371,400
+99,400
| +37% | +$2.25M | 0.01% | 1435 |
|
|
2018
Q4 | $6.19M | Sell |
272,000
-28,100
| -9% | -$765K | 0.01% | 1586 |
|
|
2018
Q3 | $9.55M | Buy |
+300,100
| New | +$9.7M | 0.01% | 1390 |
|
|
2016
Q4 | – | Sell |
-128,400
| Closed | -$1.73M | – | 3291 |
|
|
2016
Q3 | $1.73M | Buy |
128,400
+106,096
| +476% | +$2.17M | ﹤0.01% | 2278 |
|
|
2016
Q2 | $544K | Buy |
+22,304
| New | +$752K | ﹤0.01% | 2766 |
|
Other funds holding EDIT
VCM
VPM
N
OM
Jim Simons's EDIT Position: Q1 2026 in Review
Jim Simons increased its Editas Medicine (EDIT) stake by 31% in Q1 2026, buying an estimated $1.97M and bringing the position to 3,972,160 shares worth $9.81M. The position accounts for 0.02% of the portfolio, ranked #981.
Jim Simons first reported a position in EDIT in Q2 2016 and has held it in 24 quarters since. The position peaked at $19.1M in Q1 2021. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.
- Jim Simons held 3,972,160 shares of Editas Medicine worth $9.81M as of Q1 2026.
- Jim Simons bought 932,382 Editas Medicine shares in Q1 2026, an estimated $1.97M.
- Editas Medicine made up 0.02% of Jim Simons's portfolio in Q1 2026, its #981 holding.
- Jim Simons first reported a position in Editas Medicine in Q2 2016 and has held it in 24 quarters since.
- Jim Simons's Editas Medicine position peaked at $19.1M in Q1 2021.
- 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.